ImVitro is a deeptech start-up on a mission to change how embryos are selected in IVF using computer vision and AI, combined with real-world patient data.
Infertility affects millions of people of reproductive age worldwide. According to the NHS, 1 in 7 couples may have difficulty conceiving. In the United States, 10% to 15% of couples are infertile. As a result, people turn to assisted reproductive technology (ART) or in-vitro fertilization (IVF).
Imvitro's B2B SaaS platform applies computer vision and artificial intelligence to the IVF fertility imaging process. Their vision is to create an easier path to parenthood by ensuring quality control along the entire IVF workflow and personalising all medical decisions to maximize success rates.